Nature

Orlistat 60 mg reduces levels of visceral adipose tissue in obese individuals

Excess visceral adipose tissue is an important predictor of metabolic risk factors for coronary artery disease. Orlistat is a weight-loss drug (taken in conjunction with a reduced-calorie, low-fat ...
Fierce Healthcare

Press Release: FDA Approves Alli(TM) (orlistat 60 Mg Capsules) Over-The-Counter

FDA Approves Alli(TM) (orlistat 60 Mg Capsules) Over-The-Counter GlaxoSmithKline Consumer Healthcare announces today that the U.S. Food and Drug Administration (FDA) approved the weight-loss product ...
Nature

Pragmatic study of orlistat 60 mg on abdominal obesity

It is well established that combining a reduced calorie, low-fat diet with the lipase inhibitor orlistat results in significantly greater weight loss than placebo plus diet. This weight loss is ...
Medindia

Obfree (60 mg) (Orlistat) Drug Price and Information

Orlistat (Obfree (60 mg)) is a lipase inhibitor, prescribed for obesity in adults. It works by blocking the digestion of fats from the diet. The information provided on this page is intended to serve ...
FierceBiotech

Press Release: GlaxoSmithKline's First Nonprescription Diet Drug Alli Wins FDA Approval

GlaxoSmithKline's First Nonprescription Diet Drug Alli Wins FDA Approval PITTSBURGH, Feb. 7 -- GlaxoSmithKline Consumer Healthcare announces today that the U.S. Food and Drug Administration (FDA) ...
Medscape

Significant Visceral Fat Loss Seen Within 12 Weeks With Orlistat

February 3, 2010 — A randomized placebo controlled trial of orlistat (Alli, GlaxoSmithKline) 60 mg daily for overweight to obese but otherwise healthy subjects showed that the weight-loss agent was ...
Medscape

Europeans Looking Again at Orlistat and Liver Injury

September 22, 2011 (London, United Kingdom) — The European Medicines Agency (EMA) says that it has started a review of orlistat-containing medicines to determine whether the "very rare cases of ...
Pharmabiz

FDA committee to review GSK Consumer Healthcare’s proposal for Orlistat 60 capsules for OTC

The US FDA's joint Nonprescription Drugs and Endocrinologic and Metabolic Drugs Advisory Committees will review GlaxoSmithKline Consumer Healthcare’s New Drug Application for proposed over-the-counter ...
FiercePharma

FDA Drug Safety Communication: Completed safety review of Xenical/Alli (orlistat) and severe liver injury

[05-26-2010] The U.S. Food and Drug Administration (FDA) has approved a revised label for Xenical to include new safety information about cases of severe liver injury that have been reported rarely ...
Healio

FDA approves over-the-counter orlistat for weight loss

Americans will soon have a new weight loss option available on the market. The FDA has announced the approval of orlistat (Alli, GlaxoSmithKline) 60-mg capsules, for over-the-counter use in the United ...
Medindia

Olisat (60 mg) (Orlistat) Drug Price and Information

The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. Orlistat (Olisat (60 mg)) is a lipase inhibitor, ...